President & CEO of Eyepoint Pharmaceuticals Inc (30-Year Financial, Insider Trades) Nancy Lurker (insider trades) bought 98,000 shares of EYPT on 03/10/2020 at an average price of $1.06 a share. The total cost of this purchase was $103,880.
EyePoint Pharmaceuticals Inc, formerly pSivida Corp develops tiny, sustained-release, drug delivery products designed to deliver drugs at a controlled and steady rate for months or years. EyePoint Pharmaceuticals Inc has a market cap of $130.638 million; its shares were traded at around $1.05 with and P/S ratio of 7.45. GuruFocus has detected 5 severe warning signs with EyePoint Pharmaceuticals Inc. .
CEO Recent Trades:
- President & CEO Nancy Lurker bought 98,000 shares of EYPT stock on 03/10/2020 at the average price of $1.06. The price of the stock has decreased by 0.94% since.
For the complete insider trading history of EYPT, click here
.